Insulet Corp. (PODD)
147.33
-0.81
(-0.55%)
USD |
NASDAQ |
Sep 03, 10:01
Insulet Research and Development Expense (TTM) : 345.90M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 345.90M |
| March 31, 2026 | 331.20M |
| December 31, 2025 | 301.10M |
| September 30, 2025 | 270.80M |
| June 30, 2025 | 248.50M |
| March 31, 2025 | 229.00M |
| December 31, 2024 | 219.60M |
| September 30, 2024 | 201.00M |
| June 30, 2024 | 203.90M |
| March 31, 2024 | 205.10M |
| December 31, 2023 | 205.00M |
| September 30, 2023 | 212.50M |
| June 30, 2023 | 199.70M |
| March 31, 2023 | 187.20M |
| December 31, 2022 | 180.20M |
| September 30, 2022 | 172.50M |
| June 30, 2022 | 165.00M |
| March 31, 2022 | 162.50M |
| December 31, 2021 | 160.10M |
| September 30, 2021 | 156.60M |
| June 30, 2021 | 157.90M |
| March 31, 2021 | 152.00M |
| December 31, 2020 | 146.80M |
| September 30, 2020 | 143.20M |
| June 30, 2020 | 135.18M |
| Date | Value |
|---|---|
| March 31, 2020 | 133.24M |
| December 31, 2019 | 129.70M |
| September 30, 2019 | 123.51M |
| June 30, 2019 | 114.49M |
| March 31, 2019 | 100.65M |
| December 31, 2018 | 88.96M |
| September 30, 2018 | 79.23M |
| June 30, 2018 | 77.61M |
| March 31, 2018 | 77.22M |
| December 31, 2017 | 74.45M |
| September 30, 2017 | 71.70M |
| June 30, 2017 | 65.30M |
| March 31, 2017 | 60.22M |
| December 31, 2016 | 55.71M |
| September 30, 2016 | 52.57M |
| June 30, 2016 | 48.87M |
| March 31, 2016 | 47.99M |
| December 31, 2015 | 43.21M |
| September 30, 2015 | 37.60M |
| June 30, 2015 | 34.72M |
| March 31, 2015 | 29.33M |
| December 31, 2014 | 27.90M |
| September 30, 2014 | 27.04M |
| June 30, 2014 | 25.65M |
| March 31, 2014 | 24.15M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 3.128B |
| DexCom, Inc. | 604.00M |
| Boston Scientific Corp. | 2.153B |
| PROCEPT BioRobotics Corp. | 77.19M |
| Globus Medical, Inc. | 147.06M |